-
GENERATIVE ARTIFICIAL INTELLIGENCE ADOPTION AND IMPLEMENTATION BARRIERS IN KOREAN MEDICINE PRACTICE: A NATIONWIDE SURVEY
Aug 11, 2026, 17:15 PM -
WILLINGNESS TO PAY AND ENROLLMENT IN THE NATIONAL HEALTH INSURANCE PROGRAM AMONG HOUSEHOLDS IN A REMOTE DISTRICT OF NEPAL: A COMMUNITY-BASED STUDY FROM JUMLA
Aug 11, 2026, 17:15 PM -
REAL-WORLD EFFECTIVENESS OF GLP-1 RECEPTOR AGONISTS FOR OBESITY IN THE UK: FINDINGS FROM THE DICE REALM STUDY
Aug 11, 2026, 17:15 PM -
CLINICAL AND ECONOMIC BURDEN OF MEDICAL DEVICE-RELATED ADVERSE EVENTS IN INDIA: A PROSPECTIVE MATCHED NESTED CASE-CONTROL STUDY
Aug 11, 2026, 17:15 PM -
WHY ADVANCED PSORIATIC ARTHRITIS THERAPIES ARE STOPPED AND SWITCHED, BY DRUG CLASS: EVIDENCE FROM US REAL-WORLD CLINICAL NOTES
Aug 11, 2026, 17:15 PM -
A DECISION-QUESTION FRAMEWORK FOR PATIENT PREFERENCE EVIDENCE IN HTA AND HEOR
Aug 11, 2026, 17:15 PM -
GLOBAL VALUE ASSESSMENT FOR BIOLOGICS IN PSORIATIC ARTHRITIS IN THE TIME OF IRA AND MFN: DOES COST PER INCREMENTAL ACR50 RESPONDER ANALYSIS PROVIDE A CLINICALLY MEANINGFUL AND PRACTICAL CROSS-MARKET METRIC?
Aug 11, 2026, 17:15 PM -
KEY CONSIDERATIONS FOR SYNTHESIZING CROSS-COUNTRY ONCOLOGY RWE TRANSPORTABILITY STUDIES
Aug 11, 2026, 17:15 PM -
THE CHEERS CHECKLIST IN VACCINE ECONOMIC EVALUATION: A CRITICAL ANALYSIS FROM THE EPISTEMOLOGY OF COMMENSURABILITY
Aug 11, 2026, 17:15 PM -
EVALUATING MULTI-INDICATION TECHNOLOGIES: IDENTIFYING WHICH PATIENT GROUPS BENEFIT MOST AND UNDER WHAT CONDITIONS?
Aug 11, 2026, 17:15 PM -
DEVELOPING A COMPREHENSIVE FRAMEWORK FOR GENERATING PATIENT EXPERIENCE DATA IN HEALTH ECONOMICS AND OUTCOMES RESEARCH TO SUPPORT BOTH REGULATORY AND HTA REQUIREMENTS
Aug 11, 2026, 17:15 PM -
ARE QUALITY MEASURES MEASURING QUALITY? UNMASKING THE INFLUENCE OF CLINICAL AND SOCIAL RISK FACTORS
Aug 11, 2026, 17:15 PM -
THE COST OF DELAY: EVALUATING THE ECONOMIC VALUE OF RAPID OUTBREAK FINANCING DURING EBOLA RESPONSE IN UGANDA AND THE DEMOCRATIC REPUBLIC OF THE CONGO
Aug 11, 2026, 17:15 PM -
REPRESENTATIVENESS OF BROAD-CONSENT REAL-WORLD DATA: A CROSS-SECTIONAL ANALYSIS OF 3.5 MILLION INPATIENTS IN THE HELIOS SAFE MEDICAL DATA PLATFORM
Aug 11, 2026, 17:15 PM -
COMPARISON OF THE PSYCHOMETRIC PROPERTIES OF THE 3-ITEM AND 23-ITEM VERSIONS OF THE CLINICIAN ADMINISTERED DISSOCIATIVE STATES SCALE (CADSS)
Aug 11, 2026, 17:15 PM -
A HYBRID HUMAN-AI ENHANCED NOMINAL GROUP TECHNIQUE FOR EVIDENCE-BASED POLICYMAKING: DEVELOPMENT AND REAL-WORLD APPLICATION OF POLISIS
Aug 11, 2026, 17:15 PM -
HEALTH RELATED QUALITY OF LIFE MEASURED BY EQ-5D-5L AMONG PATIENTS WITH NON-SPECIFIC LOW BACK PAIN IN HONG KONG: A CROSS-SECTIONAL STUDY
Aug 11, 2026, 17:15 PM -
ROLE OF REAL-WORLD EVIDENCE IN US FDA SAFETY LABEL MODIFICATIONS - INSIGHTS FROM CASE STUDIES
Aug 11, 2026, 17:15 PM -
ENHANCING AMCP DOSSIER DEVELOPMENT THROUGH MULTIMODAL GENERATIVE AI INTERPRETATION OF TABLES, FIGURES, AND GRAPHS
Aug 11, 2026, 17:15 PM -
HEALTHCARE RESOURCE UTILIZATION AND COSTS ASSOCIATED WITH NEUTROPENIA/LEUKOPENIA-RELATED HOSPITALIZATIONS IN KIDNEY TRANSPLANT RECIPIENTS RECEIVING VALGANCICLOVIR PROPHYLAXIS IN GERMANY: A CLAIMS DATABASE STUDY
Aug 11, 2026, 17:15 PM
